| Role |
Name |
Disclosure |
Details |
| Author | David Akinpelu, MD, Staff Physician, Department of Internal Medicine, Brooklyn Hospital Center, Weill Medical College of Cornell University | Nothing to disclose | Details | | Coauthor | Javier M Gonzalez, MD, Consulting Staff, Department of Cardiology, Citrus Memorial Hospital | Nothing to disclose | Details | | Medical Editor | Justin D Pearlman, MD, PhD, ME, MA, Director of Dartmouth Advanced Imaging Center, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Ronald J Oudiz, MD, Director of Pulmonary Hypertension, Associate Professor, Department of Medicine, Division of Cardiology, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA | Actelion Encysive Gilead Pfizer United Therapeutics | Details | | CME Editor | Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital | Nothing to disclose | Details | | Chief Editor | W Robert Taylor, MD, PhD, Professor of Medicine, Division of Cardiology, Emory University; Professor of Biomedical Engineering, The Wallace H Coulter Department of Biomedical Engineering, Georgia Tech and Emory University; Consulting Staff, Department of Cardiology, Atlanta Veterans Affairs Medical Center and Emory University Hospital | Novartis Sankyo | Details |
|